Global biopharmaceutical company developing medicines for serious diseases in oncology, hematology, immunology, and cardiovascular disease, with a large India capability center in Hyderabad.
bms.comLegal name
Bristol-Myers Squibb Company
Founded
1887
Headquarters
Princeton, New Jersey, USA
Industry
Pharmaceuticals
Employees
32,500 (2025)
Revenue (FY25)
US$48.2 billion
Market Cap
US$124.42 billion (as of Jul 2026)
Listed on
NYSE: BMYCFO
David Elkins, EVP and Chief Financial Officer
Bristol-Myers Squibb Company is a US pharmaceutical company founded in 1887 and headquartered in Princeton, New Jersey, with its main corporate offices in Lawrenceville (Lawrence Township), New Jersey. It trades on the New York Stock Exchange under the ticker BMY and reported revenue of about US$48.2 billion for fiscal year 2025. The company employed roughly 32,500 people as of 2025 and had a market capitalization near US$124 billion as of July 2026.
The company is led by Chris Boerner, who serves as both Board Chair and Chief Executive Officer, with David Elkins as Executive Vice President and Chief Financial Officer. Its research and commercial work centers on serious diseases across oncology, hematology, immunology, cardiovascular disease, and fibrosis. About 69% of its 2025 revenues came from the United States market.
Bristol Myers Squibb has operated in India for more than two decades. Its Hyderabad site, inaugurated in February 2024, is described by the company as its largest office outside the United States, while Mumbai handles commercial operations and Bengaluru houses the Biocon BMS Research & Development Center (BBRC). The Hyderabad capability center operates through Bristol-Myers Squibb Business Services India Private Limited (CIN U62099TS2023FTC210700), incorporated on 7 June 2023.
Board Chair and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Executive Vice President, Chief Commercialization Officer
Executive Vice President, Chief Medical Officer and Head of Development
Interview experience
Favorable
Interview difficulty
Medium
Interview process length
About a week
Practice real questions, get instant feedback, and walk in ready.
Q: Generate a sequence of valid parentheses (focus on approach, not code).
A: Use backtracking. Build the string one bracket at a time, adding an open bracket while opens remain and a close bracket only when closes are still fewer than opens, then record each complete string of length 2n.
Q: MCQ round on data structures and predicting the output of pseudocode.
A: Trace the pseudocode line by line and track variable state, since most traps are off-by-one errors, pointer updates, or loop bounds. For data structure MCQs, anchor on time complexity and typical use cases.
Q: HR round: what are your short-term and long-term goals?
A: Tie a short-term goal to skills the role builds in the first year, then connect a long-term goal to growth inside the function. Keep it specific and honest rather than generic.
Q: Average sales of the top 10 medicines by month (SQL).
A: Aggregate sales per medicine per month, rank medicines within each month, keep the top 10, then average their sales. A window function like RANK or ROW_NUMBER over a monthly partition does the ranking cleanly.
Practice real questions, get instant feedback, and walk in ready.
Average base, India
₹12,14,624/yr
5 Salaries submitted
Average base, India
₹18,61,758/yr
5 Salaries submitted
Average base, India
₹15,87,314/yr
4 Salaries submitted
Average base, India
₹11,09,138/yr
6 Salaries submitted
Average base, India
₹22,57,716/yr
4 Salaries submitted
Average base, India
₹7,99,377/yr
3 Salaries submitted
Compare pay by role and location, then target the offer you deserve.
1+ year working with HRIS/HCM systems • Hyderabad, Telangana, India • Full-time / Hybrid
Hyderabad, Telangana, India • Full-time / Hybrid
Hyderabad, Telangana, India • Full-time / Hybrid
Hyderabad, Telangana, India • Full-time / Hybrid
Hyderabad, Telangana, India • Full-time / Hybrid
Hyderabad, Telangana, India • Full-time / Hybrid
Turn your experience into a resume that gets past screeners and into interviews.
April 30, 2026
BMS reports Q1 2026 results, reaffirms full-year guidance
Bristol Myers Squibb posted first quarter 2026 revenue of $11.5 billion, up 3% year over year (1% excluding foreign exchange), and reaffirmed its 2026 non-GAAP guidance, saying both revenue and EPS are trending toward the upper end of the ranges.
#Earnings #BMY #Pharma
View postFebruary 6, 2026
BMS beats Q4 2025 estimates and sets 2026 outlook
Bristol Myers Squibb reported Q4 2025 revenue of $12.5 billion and adjusted EPS of $1.26, both ahead of estimates, and guided 2026 revenue to roughly $46.0 to $47.5 billion with adjusted EPS of $6.05 to $6.35.
#Earnings #Guidance #BMY
View postJanuary 20, 2026
Syngene extends BMS research collaboration to 2035
India's Syngene International extended its 25-year strategic research collaboration with Bristol Myers Squibb through 2035, expanding integrated services across discovery, translational science, pharmaceutical development, manufacturing, clinical trials and IT.
#India #Partnership #RnD
View postFebruary 27, 2024
BMS opens $100 million Hyderabad innovation hub
Bristol Myers Squibb inaugurated a new science, technology and innovation center in Hyderabad backed by over $100 million in investment, expanding its drug development and digital capabilities with plans for more than 1,500 employees.
#India #Hyderabad #Expansion
View postChris Boerner leads Bristol Myers Squibb as Board Chair and Chief Executive Officer, holding both roles. David Elkins serves as Executive Vice President and Chief Financial Officer.
